StonvexLoading…
StonvexCore line items from BLKB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.13B | $1.15B | $1.11B | $1.06B |
Operating Income | $190.75M | $-271.38M | $46.35M | $-28.48M |
Net Income | $114.97M | $-299.52M | $3.02M | $-45.41M |
EPS (Diluted) | $2.37 | $-5.92 | $0.06 | $-0.88 |
Total Assets | $2.39B | $2.50B | $2.91B | $2.99B |
Total Liabilities | $2.31B | $2.37B | $2.10B | $2.25B |
Cash & Equivalents | $38.91M | $67.63M | $31.25M | $31.69M |
Free Cash Flow OCF − CapEx | $257.78M | $288.53M | $194.95M | $191.60M |
Shares Outstanding | 46.71M | 49.25M | 53.63M | 53.07M |